Global Chronic Myeloid Leukemia Treatment Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
The Global Chronic Myeloid Leukemia Treatment Drugs Market Size was estimated at USD 735.51 million in 2023 and is projected to reach USD 946.88 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Chronic Myeloid Leukemia Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Myeloid Leukemia Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Myeloid Leukemia Treatment Drugs market in any manner.
Global Chronic Myeloid Leukemia Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd.
Novartis AG
Bristol-Myers Squibb Company
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Innovent Biologics, Inc.
Viatris Inc. (Mylan N.V.)
Lupin
IL-YANG PHARM CO. LTD.
Million Health Pharmaceuticals
Celon Labs
Market Segmentation (by Type)
Tablet
Solution
Capsule
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Myeloid Leukemia Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
The Global Chronic Myeloid Leukemia Treatment Drugs Market Size was estimated at USD 735.51 million in 2023 and is projected to reach USD 946.88 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Chronic Myeloid Leukemia Treatment Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Myeloid Leukemia Treatment Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Myeloid Leukemia Treatment Drugs market in any manner.
Global Chronic Myeloid Leukemia Treatment Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd.
Novartis AG
Bristol-Myers Squibb Company
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Innovent Biologics, Inc.
Viatris Inc. (Mylan N.V.)
Lupin
IL-YANG PHARM CO. LTD.
Million Health Pharmaceuticals
Celon Labs
Market Segmentation (by Type)
Tablet
Solution
Capsule
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Chronic Myeloid Leukemia Treatment Drugs Market
- Overview of the regional outlook of the Chronic Myeloid Leukemia Treatment Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Myeloid Leukemia Treatment Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Chronic Myeloid Leukemia Treatment Drugs
1.2 Key Market Segments
1.2.1 Chronic Myeloid Leukemia Treatment Drugs Segment by Type
1.2.2 Chronic Myeloid Leukemia Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Manufacturers (2019-2024)
3.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Myeloid Leukemia Treatment Drugs Sales Sites, Area Served, Product Type
3.6 Chronic Myeloid Leukemia Treatment Drugs Market Competitive Situation and Trends
3.6.1 Chronic Myeloid Leukemia Treatment Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Myeloid Leukemia Treatment Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Chronic Myeloid Leukemia Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2024)
6.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Myeloid Leukemia Treatment Drugs Price by Type (2019-2024)
7 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Sales by Application (2019-2024)
7.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
8 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceutical Industries Ltd
9.1.1 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.1.2 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.1.4 Teva Pharmaceutical Industries Ltd Business Overview
9.1.5 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.3.2 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Bristol-Myers Squibb Company
9.4.1 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.4.2 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.4.4 Bristol-Myers Squibb Company Business Overview
9.4.5 Bristol-Myers Squibb Company Recent Developments
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.5.2 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.5.4 Pfizer Inc. Business Overview
9.5.5 Pfizer Inc. Recent Developments
9.6 Takeda Pharmaceutical Company Limited
9.6.1 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.6.2 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.6.4 Takeda Pharmaceutical Company Limited Business Overview
9.6.5 Takeda Pharmaceutical Company Limited Recent Developments
9.7 Innovent Biologics, Inc.
9.7.1 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.7.2 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.7.4 Innovent Biologics, Inc. Business Overview
9.7.5 Innovent Biologics, Inc. Recent Developments
9.8 Viatris Inc. (Mylan N.V.)
9.8.1 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.8.2 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.8.4 Viatris Inc. (Mylan N.V.) Business Overview
9.8.5 Viatris Inc. (Mylan N.V.) Recent Developments
9.9 Lupin
9.9.1 Lupin Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.9.2 Lupin Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.9.3 Lupin Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.9.4 Lupin Business Overview
9.9.5 Lupin Recent Developments
9.10 IL-YANG PHARM CO. LTD.
9.10.1 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.10.2 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.10.4 IL-YANG PHARM CO. LTD. Business Overview
9.10.5 IL-YANG PHARM CO. LTD. Recent Developments
9.11 Million Health Pharmaceuticals
9.11.1 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.11.4 Million Health Pharmaceuticals Business Overview
9.11.5 Million Health Pharmaceuticals Recent Developments
9.12 Celon Labs
9.12.1 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.12.4 Celon Labs Business Overview
9.12.5 Celon Labs Recent Developments
10 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET FORECAST BY REGION
10.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast
10.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region
10.2.4 South America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Myeloid Leukemia Treatment Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Myeloid Leukemia Treatment Drugs by Type (2025-2030)
11.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Myeloid Leukemia Treatment Drugs by Type (2025-2030)
11.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Chronic Myeloid Leukemia Treatment Drugs
1.2 Key Market Segments
1.2.1 Chronic Myeloid Leukemia Treatment Drugs Segment by Type
1.2.2 Chronic Myeloid Leukemia Treatment Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Manufacturers (2019-2024)
3.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Myeloid Leukemia Treatment Drugs Sales Sites, Area Served, Product Type
3.6 Chronic Myeloid Leukemia Treatment Drugs Market Competitive Situation and Trends
3.6.1 Chronic Myeloid Leukemia Treatment Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Myeloid Leukemia Treatment Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Chronic Myeloid Leukemia Treatment Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2024)
6.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Myeloid Leukemia Treatment Drugs Price by Type (2019-2024)
7 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Sales by Application (2019-2024)
7.3 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
8 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva Pharmaceutical Industries Ltd
9.1.1 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.1.2 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.1.4 Teva Pharmaceutical Industries Ltd Business Overview
9.1.5 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.1.6 Teva Pharmaceutical Industries Ltd Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.3.2 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Bristol-Myers Squibb Company
9.4.1 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.4.2 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.4.4 Bristol-Myers Squibb Company Business Overview
9.4.5 Bristol-Myers Squibb Company Recent Developments
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.5.2 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.5.4 Pfizer Inc. Business Overview
9.5.5 Pfizer Inc. Recent Developments
9.6 Takeda Pharmaceutical Company Limited
9.6.1 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.6.2 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.6.4 Takeda Pharmaceutical Company Limited Business Overview
9.6.5 Takeda Pharmaceutical Company Limited Recent Developments
9.7 Innovent Biologics, Inc.
9.7.1 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.7.2 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.7.4 Innovent Biologics, Inc. Business Overview
9.7.5 Innovent Biologics, Inc. Recent Developments
9.8 Viatris Inc. (Mylan N.V.)
9.8.1 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.8.2 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.8.4 Viatris Inc. (Mylan N.V.) Business Overview
9.8.5 Viatris Inc. (Mylan N.V.) Recent Developments
9.9 Lupin
9.9.1 Lupin Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.9.2 Lupin Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.9.3 Lupin Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.9.4 Lupin Business Overview
9.9.5 Lupin Recent Developments
9.10 IL-YANG PHARM CO. LTD.
9.10.1 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.10.2 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.10.4 IL-YANG PHARM CO. LTD. Business Overview
9.10.5 IL-YANG PHARM CO. LTD. Recent Developments
9.11 Million Health Pharmaceuticals
9.11.1 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.11.4 Million Health Pharmaceuticals Business Overview
9.11.5 Million Health Pharmaceuticals Recent Developments
9.12 Celon Labs
9.12.1 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Basic Information
9.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Overview
9.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Market Performance
9.12.4 Celon Labs Business Overview
9.12.5 Celon Labs Recent Developments
10 CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS MARKET FORECAST BY REGION
10.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast
10.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region
10.2.4 South America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Myeloid Leukemia Treatment Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Myeloid Leukemia Treatment Drugs by Type (2025-2030)
11.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Myeloid Leukemia Treatment Drugs by Type (2025-2030)
11.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Chronic Myeloid Leukemia Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment Drugs as of 2022)
Table 10. Global Market Chronic Myeloid Leukemia Treatment Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Chronic Myeloid Leukemia Treatment Drugs Sales Sites and Area Served
Table 12. Manufacturers Chronic Myeloid Leukemia Treatment Drugs Product Type
Table 13. Global Chronic Myeloid Leukemia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Chronic Myeloid Leukemia Treatment Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chronic Myeloid Leukemia Treatment Drugs Market Challenges
Table 22. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Type (Kilotons)
Table 23. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Type (M USD)
Table 24. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Share by Type (2019-2024)
Table 28. Global Chronic Myeloid Leukemia Treatment Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Application
Table 30. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Application
Table 31. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application (2019-2024)
Table 35. Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 44. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 45. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceutical Industries Ltd Business Overview
Table 47. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 48. Teva Pharmaceutical Industries Ltd Recent Developments
Table 49. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 50. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 51. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 54. F. Hoffmann-La Roche Ltd. Recent Developments
Table 55. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 56. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 57. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 62. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 63. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Company Business Overview
Table 65. Bristol-Myers Squibb Company Recent Developments
Table 66. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 67. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 68. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Recent Developments
Table 71. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 72. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 73. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Takeda Pharmaceutical Company Limited Business Overview
Table 75. Takeda Pharmaceutical Company Limited Recent Developments
Table 76. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 77. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 78. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Innovent Biologics, Inc. Business Overview
Table 80. Innovent Biologics, Inc. Recent Developments
Table 81. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 82. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 83. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Viatris Inc. (Mylan N.V.) Business Overview
Table 85. Viatris Inc. (Mylan N.V.) Recent Developments
Table 86. Lupin Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 87. Lupin Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 88. Lupin Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lupin Business Overview
Table 90. Lupin Recent Developments
Table 91. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 92. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 93. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. IL-YANG PHARM CO. LTD. Business Overview
Table 95. IL-YANG PHARM CO. LTD. Recent Developments
Table 96. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 97. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 98. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Million Health Pharmaceuticals Business Overview
Table 100. Million Health Pharmaceuticals Recent Developments
Table 101. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 102. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 103. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Celon Labs Business Overview
Table 105. Celon Labs Recent Developments
Table 106. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Chronic Myeloid Leukemia Treatment Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Chronic Myeloid Leukemia Treatment Drugs Market Size Comparison by Region (M USD)
Table 5. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Chronic Myeloid Leukemia Treatment Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment Drugs as of 2022)
Table 10. Global Market Chronic Myeloid Leukemia Treatment Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Chronic Myeloid Leukemia Treatment Drugs Sales Sites and Area Served
Table 12. Manufacturers Chronic Myeloid Leukemia Treatment Drugs Product Type
Table 13. Global Chronic Myeloid Leukemia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Chronic Myeloid Leukemia Treatment Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chronic Myeloid Leukemia Treatment Drugs Market Challenges
Table 22. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Type (Kilotons)
Table 23. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Type (M USD)
Table 24. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Share by Type (2019-2024)
Table 28. Global Chronic Myeloid Leukemia Treatment Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) by Application
Table 30. Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Application
Table 31. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application (2019-2024)
Table 35. Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Chronic Myeloid Leukemia Treatment Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 44. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 45. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Pharmaceutical Industries Ltd Business Overview
Table 47. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 48. Teva Pharmaceutical Industries Ltd Recent Developments
Table 49. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 50. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 51. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 54. F. Hoffmann-La Roche Ltd. Recent Developments
Table 55. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 56. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 57. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Chronic Myeloid Leukemia Treatment Drugs SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 62. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 63. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Company Business Overview
Table 65. Bristol-Myers Squibb Company Recent Developments
Table 66. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 67. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 68. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Recent Developments
Table 71. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 72. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 73. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Takeda Pharmaceutical Company Limited Business Overview
Table 75. Takeda Pharmaceutical Company Limited Recent Developments
Table 76. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 77. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 78. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Innovent Biologics, Inc. Business Overview
Table 80. Innovent Biologics, Inc. Recent Developments
Table 81. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 82. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 83. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Viatris Inc. (Mylan N.V.) Business Overview
Table 85. Viatris Inc. (Mylan N.V.) Recent Developments
Table 86. Lupin Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 87. Lupin Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 88. Lupin Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lupin Business Overview
Table 90. Lupin Recent Developments
Table 91. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 92. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 93. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. IL-YANG PHARM CO. LTD. Business Overview
Table 95. IL-YANG PHARM CO. LTD. Recent Developments
Table 96. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 97. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 98. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Million Health Pharmaceuticals Business Overview
Table 100. Million Health Pharmaceuticals Recent Developments
Table 101. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Basic Information
Table 102. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product Overview
Table 103. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Celon Labs Business Overview
Table 105. Celon Labs Recent Developments
Table 106. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Chronic Myeloid Leukemia Treatment Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Chronic Myeloid Leukemia Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD), 2019-2030
Figure 5. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chronic Myeloid Leukemia Treatment Drugs Market Size by Country (M USD)
Figure 11. Chronic Myeloid Leukemia Treatment Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 13. Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Chronic Myeloid Leukemia Treatment Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Chronic Myeloid Leukemia Treatment Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Type
Figure 18. Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type in 2023
Figure 20. Market Size Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application
Figure 24. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application in 2023
Figure 26. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application (2019-2024)
Figure 27. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application in 2023
Figure 28. Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Chronic Myeloid Leukemia Treatment Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 37. Germany Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region in 2023
Figure 44. China Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Chronic Myeloid Leukemia Treatment Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Chronic Myeloid Leukemia Treatment Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Chronic Myeloid Leukemia Treatment Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD), 2019-2030
Figure 5. Global Chronic Myeloid Leukemia Treatment Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chronic Myeloid Leukemia Treatment Drugs Market Size by Country (M USD)
Figure 11. Chronic Myeloid Leukemia Treatment Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Share by Manufacturers in 2023
Figure 13. Chronic Myeloid Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Chronic Myeloid Leukemia Treatment Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Chronic Myeloid Leukemia Treatment Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Type
Figure 18. Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type in 2023
Figure 20. Market Size Share of Chronic Myeloid Leukemia Treatment Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Chronic Myeloid Leukemia Treatment Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application
Figure 24. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Application in 2023
Figure 26. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application (2019-2024)
Figure 27. Global Chronic Myeloid Leukemia Treatment Drugs Market Share by Application in 2023
Figure 28. Global Chronic Myeloid Leukemia Treatment Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Chronic Myeloid Leukemia Treatment Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Chronic Myeloid Leukemia Treatment Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 37. Germany Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region in 2023
Figure 44. China Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Chronic Myeloid Leukemia Treatment Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Chronic Myeloid Leukemia Treatment Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Chronic Myeloid Leukemia Treatment Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Chronic Myeloid Leukemia Treatment Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Chronic Myeloid Leukemia Treatment Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Chronic Myeloid Leukemia Treatment Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Chronic Myeloid Leukemia Treatment Drugs Market Share Forecast by Application (2025-2030)
